Sodium-glucose cotransporter-2 inhibitor use prior to the onset of COVID-19 infection was associated with the lowest risk for adverse outcomes in patients with diabetes.
All articles by Janelle Barowski, MSN RN
Researchers evaluated the safety and efficacy of ensitrelvir for the treatment of mild to moderate COVID-19 infection during the Omicron wave.
Researchers evaluated the short-term safety profile of a second booster dose of a COVID-19 mRNA vaccine.
Researchers compared the presence of symptoms 2 years after acute COVID-19 infection between hospitalized and nonhospitalized patients.
Researchers evaluated the effectiveness of bivalent mRNA COVID-19 vaccination among adults who previously received at least 2 monovalent vaccine doses.